SCHEMBL27206428

SCHEMBL27206428

Cc1ccc(NC(=O)C(CC2CCCC2)NC(=O)OC(C)(C)C)cn1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CTSS P25774 2/20 0.53
▸ CTSK P43235 2/20 0.53
▸ AAK1 Q2M2I8 2/20 0.52
▸ USP30 Q70CQ3 7/20 0.48
▸ FPR2 P25090 2/20 0.48
▸ MEN1 O00255 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ HDAC4 P56524 2/20 0.43
▸ HDAC1 Q13547 2/20 0.43
▸ KLK7 P49862 1/20 0.42
▸ HDAC3 O15379 1/20 0.42
▸ HDAC7 Q8WUI4 1/20 0.42
▸ HDAC2 Q92769 1/20 0.42
▸ HDAC10 Q969S8 1/20 0.42
▸ HDAC11 Q96DB2 1/20 0.42
▸ HDAC8 Q9BY41 1/20 0.42
▸ HDAC6 Q9UBN7 1/20 0.42
▸ HDAC9 Q9UKV0 1/20 0.42
▸ HDAC5 Q9UQL6 1/20 0.42
▸ EHMT2 Q96KQ7 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27192584 1.00 CTSS (0.53) CTSSCTSKAAK1USP30FPR2
SCHEMBL26436553 0.87 EHMT2 (0.54) CTSSCTSKAAK1MEN1KMT2A
SCHEMBL26436561 0.87 EHMT2 (0.54) CTSSCTSKAAK1MEN1KMT2A
SCHEMBL27192711 0.82 CTSS (0.58) CTSSCTSKAAK1USP30FPR2
SCHEMBL27192706 0.82 CTSS (0.58) CTSSCTSKAAK1USP30FPR2
SCHEMBL28609000 0.78 CTSS (0.48) CTSSCTSKAAK1USP30FPR2
SCHEMBL27192808 0.78 CTSS (0.55) CTSSCTSKAAK1USP30HDAC4
SCHEMBL27192669 0.78 CTSS (0.55) CTSSCTSKAAK1USP30HDAC4
SCHEMBL9072905 0.77 CTSS (0.52) CTSSCTSKAAK1USP30
SCHEMBL9072799 0.77 CTSS (0.52) CTSSCTSKAAK1USP30

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240116910-A1 Heterocycles as WIP1 Inhibitors PMV PHARMACEUTICALS, INC. 2024-04-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240116910-A1 Heterocycles as WIP1 Inhibitors WAPL, WHR1, G3BP1 CTSS 3045/4885CTSK 3237/4885AAK1 1283/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback